Get the Stockscreener App
8.84
1.96%
0.17
After Hours:
8.84
Omeros Corporation Stock (OMER) Latest News
Omeros (NASDAQ:OMER) Trading Up 5.3%Here's What Happened - MarketBeat
Omeros (NASDAQ:OMER) Stock Price Down 4.4%Here's Why - MarketBeat
Omeros jumps as lead drug succeeds in pivotal trial for blood transplant patients - MSN
Cantor Fitzgerald Forecasts Omeros FY2025 Earnings - Defense World
Omeros (NASDAQ:OMER) Shares Gap DownTime to Sell? - MarketBeat
Cantor Fitzgerald Comments on Omeros FY2025 Earnings - MarketBeat
Omeros’ (OMER) Hold Rating Reiterated at Needham & Company LLC - Defense World
Barclays PLC Acquires 51,873 Shares of Omeros Co. (NASDAQ:OMER) - MarketBeat
Barclays PLC Has $376,000 Holdings in Omeros Co. (NASDAQ:OMER) - Defense World
Omeros (NASDAQ:OMER) Earns “Buy” Rating from D. Boral Capital - Defense World
Omeros Corporation Announces Statistical Sensitivity Analyses Results for Narsoplimab - Defense World
Needham & Company LLC Reaffirms Hold Rating for Omeros (NASDAQ:OMER) - MarketBeat
Omeros (NASDAQ:OMER) Stock Price Up 5.5%Time to Buy? - MarketBeat
D. Boral Capital Reiterates Buy Rating for Omeros (NASDAQ:OMER) - MarketBeat
Narsoplimab shows promise in reducing mortality for TA-TMA patients - MSN
Omeros Co. (NASDAQ:OMER) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Omeros Co. (NASDAQ:OMER) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Personal Finance - Business Wire
Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint - Business Wire
Jane Street Group LLC Has $231,000 Stock Holdings in Omeros Co. (NASDAQ:OMER) - Defense World
When the Price of (OMER) Talks, People Listen - Stock Traders Daily
Mydriasis Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Viatris/Ocuphire Pharma, Eyenovia, Rayner Surgical/Omeros, Eyenovia Inc - The Globe and Mail
United Rentals (URI-N) QuotePress Release - The Globe and Mail
Omeros (NASDAQ:OMER) Stock Price Down 3.1%Time to Sell? - MarketBeat
Geode Capital Management LLC Has $5.32 Million Position in Omeros Co. (NASDAQ:OMER) - Defense World
Omeros Co. (NASDAQ:OMER) Shares Acquired by Barclays PLC - Defense World
Omeros (NASDAQ:OMER) Trading Up 10.3%Time to Buy? - MarketBeat
Omeros (NASDAQ:OMER) Shares Gap UpShould You Buy? - MarketBeat
State Street Corp Has $4.87 Million Stock Position in Omeros Co. (NASDAQ:OMER) - Defense World
Omeros (NASDAQ:OMER) Shares Up 3.6% – Here’s Why - Defense World
MML Investors Services LLC Purchases 3,000 Shares of Omeros Co. (NASDAQ:OMER) - Defense World
Omeros (NASDAQ:OMER) Stock Price Up 3.6%What's Next? - MarketBeat
When Can We Expect A Profit From Omeros Corporation (NASDAQ:OMER)? - Yahoo Finance
Brokerages Set Omeros Co. (NASDAQ:OMER) Price Target at $22.50 - Defense World
HighTower Advisors LLC Increases Stock Position in Omeros Co. (NASDAQ:OMER) - Defense World
Omeros shares climb as D. Boral Capital initiates with Buy By Investing.com - Investing.com Australia
Omeros shares climb as D. Boral Capital initiates with Buy - Investing.com India
Omeros (NASDAQ:OMER) Now Covered by Analysts at D. Boral Capital - Defense World
retail investors who own 52% along with institutions invested in Omeros Corporation (NASDAQ:OMER) saw increase in their holdings value last week - Simply Wall St
This Omeros Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Omeros (NASDAQ:OMER) Now Covered by D. Boral Capital - MarketBeat
Omeros (NASDAQ:OMER) Hits New 52-Week High – Here’s Why - Defense World
5.49%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):